News Related to Orbital Therapeutics

Related coverage linked through entity extraction aliases.

Bristol Myers Squibb Growth Portfolio Offsets Legacy Drug Declines in 2025

Mar 03, 2026

Bristol Myers Squibb's growth portfolio increased 17% in 2025, partially offsetting a 15% decline in legacy products facing generic competition. The company's stock gained 11.4% in the past month on strong fourth-quarter results.

In Vivo CAR-T Technology and Community Delivery Expand Cancer Treatment Access

Feb 28, 2026

Next-generation in vivo CAR-T therapy enables cancer treatment with a single injection, while new Texas legislation and community-based delivery models expand patient access to this advanced cellular therapy.